Header01-REBRAND_MENARINISILICONBIOSYSTEMS

 

Press Releases

06/7/2021

Menarini’s CELLSEARCH® Circulating Endothelial Cells assay to monitor systemic sclerosis in clinical research studies: new data presented at the 2021 EULAR Congress


This non-invasive test leverages the Gold Standard CELLSEARCH platform to enumerate Circulating Endothelial Cells from blood and may provide novel and valuable information on systemic sclerosis disease. The test is available to all professionals as a lab service in Europe and the US.

continue →

Topics: CELLSEARCH, CECs, Circulating Endothelial Cells, Lab Services, Systemic Sclerosis

03/31/2021

Menarini Silicon Biosystems launches CELLSEARCH® Circulating Multiple Myeloma Cells Assay, a new non-invasive test to monitor disease status in clinical research studies


The new test, available as a Lab Service throughout Europe and US, leverages the Gold Standard CELLSEARCH platform to enumerate Circulating Multiple Myeloma Cells from blood and offers real-time standardized monitoring of multiple myeloma in clinical research studies.

continue →

Topics: CELLSEARCH, Multiple myeloma, CMMCs, Lab Services